TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11175677

Group type: EXPERIMENTAL
Intervention: Timed Movement Battery (TMB) at self‐selected speeds
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Timed Movement Battery (TMB) at maximum‐movement speeds
Number of subjects: 30

Group type: COMPARATOR
Intervention: Criterion tests (Berg Balance Scale, Timed 'Up & Go' Test, Barthel Index, and 18‐item ADL/IADL scale)
Number of subjects: 30
Study: 9753210

Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Troglitazone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 12
Study: 7801757

Group type: EXPERIMENTAL
Intervention: Cooled saw blade
Number of subjects: 33

Group type: COMPARATOR
Intervention: Conventional blade
Number of subjects: 33
Study: 3140734

Group type: EXPERIMENTAL
Intervention: MMC and FT-207
Number of subjects: 54

Group type: COMPARATOR
Intervention: MMC and UFT
Number of subjects: 54
Study: 31017306

Group type: EXPERIMENTAL
Intervention: Zhang's guideline
Number of subjects: 7277

Group type: COMPARATOR
Intervention: WHO partograph
Number of subjects: 7277
Study: 26114393

Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine added to University of Wisconsin solution
Number of subjects: 115

Group type: COMPARATOR
Intervention: Standard University of Wisconsin solution
Number of subjects: 115
Study: 25174261

Group type: EXPERIMENTAL
Intervention: Imiquimod 3.75%
Number of subjects: 42
Study: 24194754

Group type: EXPERIMENTAL
Intervention: Dorsal onlay BMG urethroplasty
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ventral BMG urethroplasty
Number of subjects: 40
Study: 20734028

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (cycling at 75% of VO(2peak))
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Power exercise (leg press at 75% of one repetition maximum plus jumping sequence)
Number of subjects: 28
Study: 19957874

Group type: EXPERIMENTAL
Intervention: CHO trial (6.4% w/v glucose and maltodextrin solution)
Number of subjects: 7

Group type: COMPARATOR
Intervention: PLA trial (placebo solution)
Number of subjects: 7
Study: 16749411

Group type: EXPERIMENTAL
Intervention: Active pulsed electromagnetic therapy (PEMT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 36
Study: 15090561

Group type: EXPERIMENTAL
Intervention: Clozapine (mean dosage 35.8 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clozapine and Placebo
Number of subjects: 60
Study: 11331953

Group type: EXPERIMENTAL
Intervention: Initial review of 125 slides by 12 pathologists
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Second review of 125 slides by 12 pathologists
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Analysis using 4 diagnostic categories (BE; IND; LGD; HGD and carcinoma)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Analysis of interobserver agreement for HGD/carcinoma
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Analysis of interobserver agreement for BE
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Analysis of interobserver agreement for LGD
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Analysis of interobserver agreement for IND
Number of subjects: 250
Study: 9173967

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Dexamethasone (4 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (100 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Dexamethasone (1 mg) suppression test
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Arginine vasopressin (AVP) infusion
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Behavioral characteristics
Number of subjects: 15
Study: 7930246

Group type: EXPERIMENTAL
Intervention: Prourokinase (60 mg or 80 mg monotherapy or 60 mg primed with 250,000 IU recombinant urokinase)
Number of subjects: 128
Study: 2856053

Group type: EXPERIMENTAL
Intervention: High potassium diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low sodium diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low sodium, high potassium diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 31689482

Group type: EXPERIMENTAL
Intervention: Loxoprofen sodium (60 mg once orally)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 229
Study: 31158346

Group type: EXPERIMENTAL
Intervention: Valerian 100 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Midazolam 15 mg
Number of subjects: 20
Study: 28088498

Group type: EXPERIMENTAL
Intervention: Misoprostol 400 mcg vaginally
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 26634113

Group type: EXPERIMENTAL
Intervention: Water based extract of propolis mouth wash (15 ml, 3 times a day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo mouth wash (15 ml)
Number of subjects: 20
Study: 24279229

Group type: EXPERIMENTAL
Intervention: Simulated altitude of 25,000 ft (7620 m)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulated altitude of 17,500 ft (5334 m)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 0
Study: 20872023

Group type: EXPERIMENTAL
Intervention: Haptics-trained group
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Nonhaptics-trained group
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 33
Study: 19092152

Group type: EXPERIMENTAL
Intervention: Alfuzosin 10 mg per day for 12 weeks
Number of subjects: 272

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 272
Study: 22773108

Group type: EXPERIMENTAL
Intervention: Copeland RHHI
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Global C.A.P RHHI
Number of subjects: 21

Group type: COMPARATOR
Intervention: Both RHHI groups
Number of subjects: 21
Study: 15949728

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) at doses of 0.05, 0.2, and 0.5 microg/kg/min
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Nitric oxide (NO) at doses of 40, 60, and 80 ppm
Number of subjects: 19
Study: 12566659

Group type: EXPERIMENTAL
Intervention: Increase in peritoneal solute clearance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Residual renal function
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General findings
Number of subjects: 0
Study: 10630057

Group type: EXPERIMENTAL
Intervention: Obstetric analgesia by peridural way (Group I)
Number of subjects: 129

Group type: COMPARATOR
Intervention: No analgesia (Group II)
Number of subjects: 129
Study: 7995764

Group type: EXPERIMENTAL
Intervention: Conformal radiation treatment
Number of subjects: 409

Group type: COMPARATOR
Intervention: Standard radiation treatment
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Conformal technique in patients 65 years or older
Number of subjects: 409

Group type: COMPARATOR
Intervention: Standard technique in patients 65 years or older
Number of subjects: 409
Study: 2186980

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg at 8 am
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg at 10 pm
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 471152

Group type: EXPERIMENTAL
Intervention: MK-196 (20, 40, 60, 80 mg)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Frusemide (40 mg)
Number of subjects: 5
Study: 12756629

Group type: EXPERIMENTAL
Intervention: Instrumented fusion
Number of subjects: 109

Group type: COMPARATOR
Intervention: Non-instrumented fusion
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Non-organic pain group
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Working patients
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Overall spinal fusion patients
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Pain drawings
Number of subjects: 109
Study: 29597305

Group type: EXPERIMENTAL
Intervention: Alcohol with carbohydrate (25 g sucrose)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Alcohol with artificial sweetener (aspartame)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Alcohol consumption (20 g for males; 10 g for females)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: NDARC advised alcohol quantities
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Alcohol with artificially-sweetened mixers
Number of subjects: 32
Study: 26581681

Group type: EXPERIMENTAL
Intervention: 42 g walnuts/d
Number of subjects: 18

Group type: COMPARATOR
Intervention: unsupplemented base diet
Number of subjects: 18
Study: 25060482

Group type: EXPERIMENTAL
Intervention: Sedentary behavior (highest levels)
Number of subjects: 1730

Group type: EXPERIMENTAL
Intervention: Sedentary behavior (second quartile)
Number of subjects: 1730

Group type: EXPERIMENTAL
Intervention: Sedentary behavior (third quartile)
Number of subjects: 1730

Group type: EXPERIMENTAL
Intervention: Sedentary behavior (fourth quartile)
Number of subjects: 1730
Study: 22496174

Group type: EXPERIMENTAL
Intervention: 5‐ to 10‐minute educational intervention in a pediatric clinic
Number of subjects: 129
Study: 20647083

Group type: EXPERIMENTAL
Intervention: Negative apical pressure device (EndoVac; Discus Dental, Culver City, CA)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Needle irrigation (Max‐i‐Probe; Dentsply Rinn, Elgin, IL)
Number of subjects: 110
Study: 18823180

Group type: EXPERIMENTAL
Intervention: Telephone counseling intervention
Number of subjects: 0
Study: 16644335

Group type: EXPERIMENTAL
Intervention: Optimized biventricular pacing (OPT)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Simultaneous biventricular pacing
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: CRT-D (both groups)
Number of subjects: 121
Study: 12544674

Group type: EXPERIMENTAL
Intervention: Constant‐estrogen, intermittent‐progestogen hormone replacement regimen (Ortho‐Prefest)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study: 11018622

Group type: EXPERIMENTAL
Intervention: Melanotan II (0.025 mg/kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 9054308

Group type: EXPERIMENTAL
Intervention: Forlax
Number of subjects: 256

Group type: COMPARATOR
Intervention: Transipeg
Number of subjects: 256
Study: 1633793

Group type: EXPERIMENTAL
Intervention: Isometric stoop lifting efforts with 60 degrees hip flexion
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isometric stoop lifting efforts with 90 degrees hip flexion
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isometric squat lifting efforts with 90 degrees knee flexion
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isometric squat lifting efforts with 135 degrees knee flexion
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isokinetic lifts at 50cm/s
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Self-selected optimal postures
Number of subjects: 30
Study: 6437579

Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg once daily
Number of subjects: 197

Group type: COMPARATOR
Intervention: Cimetidine 400 mg twice daily
Number of subjects: 197
Study: 31091064

Group type: EXPERIMENTAL
Intervention: PRIMER protocol (intrauterine PRP injection and subcutaneous G-CSF injection)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (first IVF/ICSI attempt without PRP or G-CSF injection)
Number of subjects: 33
Study: 30030584

Group type: EXPERIMENTAL
Intervention: GLIF combination chemotherapy (gemcitabine 800 mg/m2, levofolinate 100 mg/m2, irinotecan 80 mg/m2, 5-FU 1000 mg/m2)
Number of subjects: 28
Study: 25933139

Group type: EXPERIMENTAL
Intervention: Pegylated interferon and ribavirin treatment
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Very rapid virologic response (VRVR) group (1.5 log decrease in HCV RNA levels at the first week)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Non-VRVR group (without 1.5 log decrease in HCV RNA levels at the first week)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Rapid virologic response group
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Early virologic response group
Number of subjects: 52
Study: 24041564

Group type: EXPERIMENTAL
Intervention: VoorZorg programme (nurse home visitation intervention)
Number of subjects: 460

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 460
Study: 22551472

Group type: EXPERIMENTAL
Intervention: Strengthening Families Programme 10-14 (SFP10-14)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control arm (no intervention)
Number of subjects: 0
Study: 20403817

Group type: EXPERIMENTAL
Intervention: Chronic atrial fibrillation (AF) in patients with ischaemic heart disease (IHD)
Number of subjects: 2881

Group type: EXPERIMENTAL
Intervention: Chronic atrial fibrillation (AF) in patients without ischaemic heart disease (IHD)
Number of subjects: 2881
Study: 17908884

Group type: EXPERIMENTAL
Intervention: Autologous chondrocyte implantation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Microfracture
Number of subjects: 80
Study: 16055231

Group type: EXPERIMENTAL
Intervention: Combined two-dose hepatitis A and B vaccine (720ELU HAV, 20 mcg HBsAg)
Number of subjects: 511

Group type: COMPARATOR
Intervention: Established three-dose hepatitis A and B vaccine (360ELU HAV, 10 mcg HBsAg)
Number of subjects: 511
Study: 12015785

Group type: EXPERIMENTAL
Intervention: Retrospective pretest ratings
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Prospective assessments
Number of subjects: 251

Group type: COMPARATOR
Intervention: Current assessments
Number of subjects: 251
Study: 10028739

Group type: EXPERIMENTAL
Intervention: Double gloving (Regent 'Reveal' perforation indication system or standard surgical gloves)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Single gloves (Regent Biogel D or standard surgical gloves)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Glove perforation indication system
Number of subjects: 138
Study: 7782272

Group type: EXPERIMENTAL
Intervention: Phenelzine (monamine oxidase inhibitor)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brofaromine (reversible monamine oxidase inhibitor)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moclobemide (reversible monamine oxidase inhibitor)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (serotonin selective reuptake inhibitor)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sertraline (serotonin selective reuptake inhibitor)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clonazepam (benzodiazepine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta‐adrenergic receptor blockers
Number of subjects: 0
Study: 2274738

Group type: EXPERIMENTAL
Intervention: K type pouch
Number of subjects: 30

Group type: COMPARATOR
Intervention: J type pouch
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: STP patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: Historical controls (endoanal mucosectomy and hand-sutured pouch-anal anastomosis)
Number of subjects: 30
Study: 6270994

Group type: EXPERIMENTAL
Intervention: High fiber diet
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Castor oil
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Milk of magnesia and cascara
Number of subjects: 309

Group type: COMPARATOR
Intervention: No preparation
Number of subjects: 309
Study: 31881181

Group type: EXPERIMENTAL
Intervention: ADVIA Centaur® XP system for insulin determination
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Insulin assay applied in bioequivalence study of miglitol
Number of subjects: 48
Study: 31848175

Group type: EXPERIMENTAL
Intervention: CPES responders
Number of subjects: 103186

Group type: COMPARATOR
Intervention: Cancer registry population
Number of subjects: 103186
Study: 28276638

Group type: EXPERIMENTAL
Intervention: Zoledronic acid 5 mg/year
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Zoledronic acid 5 mg treatment
Number of subjects: 285

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Zoledronic acid 5 mg
Number of subjects: 285
Study: 27669539

Group type: EXPERIMENTAL
Intervention: Nausea without vomiting
Number of subjects: 797

Group type: EXPERIMENTAL
Intervention: Nausea with vomiting
Number of subjects: 797

Group type: EXPERIMENTAL
Intervention: Nausea
Number of subjects: 797
Study: 23895390

Group type: EXPERIMENTAL
Intervention: Manipulation of interpupillary distance (IPD) as the unit for binocular perception of distance using vergence angles.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulation of eye height (EH) as the unit for monocular perception of distance using elevation angles.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perturbation of simultaneously available IPD and EH units.
Number of subjects: 0
Study: 22305183

Group type: EXPERIMENTAL
Intervention: Intravenous acetylcysteine (50 mg/kg/hr for 2 hrs before contrast exposure, then 20 mg/kg/hr for 5 hrs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral acetylcysteine (1200 mg twice daily for 2 days, starting the day before contrast exposure)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 19914558

Group type: EXPERIMENTAL
Intervention: Various interventions from randomized controlled trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group from randomized controlled trials
Number of subjects: 0
Study: 17693976

Group type: EXPERIMENTAL
Intervention: Oral estrogen replacement therapy (2 mg/day)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Transdermal estrogen replacement therapy (0.05 mg/day)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (20 healthy female subjects, 47+/‐5 years)
Number of subjects: 41
Study: 15767218

Group type: EXPERIMENTAL
Intervention: Valproate MR granules administered once/day or twice/day (500 mg)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Valproate MR granules administered with yogurt or after a high-fat meal
Number of subjects: 75

Group type: COMPARATOR
Intervention: Existing valproate SR formulations
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Valproate MR granules
Number of subjects: 75
Study: 12410497

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) orally (600 mg) plus saline every 12 hr for 24 hr before and after the procedure
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Fenoldopam (0.1 microg/kg/min) plus saline for 4 hr prior and 4 hr after the procedure
Number of subjects: 123

Group type: COMPARATOR
Intervention: Saline (0.45% normal saline at 1 cc/kg) for 12 hr before and 12 hr after the procedure
Number of subjects: 123
Study: 10519498

Group type: EXPERIMENTAL
Intervention: Lidocaine with epinephrine (2.5 microg/ml)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Plain lidocaine (1%)
Number of subjects: 8
Study: 8550123

Group type: EXPERIMENTAL
Intervention: Pilocarpine nitrate (2%) 10 microliters
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pilocarpine nitrate (2%) 20 microliters
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pilocarpine nitrate (2%) 40 microliters
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pilocarpine nitrate (2%) 80 microliters
Number of subjects: 12
Study: 1741534

Group type: EXPERIMENTAL
Intervention: Theophylline (T)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 12
Study: 6127901

Group type: EXPERIMENTAL
Intervention: Prenalterol (20 mg in controlled release preparation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prenalterol (oral administration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prenalterol (intravenous administration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prenalterol (intravenous dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prenalterol (oral dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prenalterol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prenalterol (solution)
Number of subjects: 0
Study: 30565716

Group type: EXPERIMENTAL
Intervention: Behavioural modification programme
Number of subjects: 68

Group type: COMPARATOR
Intervention: Minimal intervention
Number of subjects: 68
Study: 29346837

Group type: EXPERIMENTAL
Intervention: Ertugliflozin (100 mg; supratherapeutic dose)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Moxifloxacin (400 mg; positive control)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 27503124

Group type: EXPERIMENTAL
Intervention: Weng-li-tong (WLT)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Tolterodine
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Weng-li-tong plus Tolterodine
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182
Study: 24616624

Group type: EXPERIMENTAL
Intervention: Aneroid Blood Pressure (ABP) monitoring
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Oscillometric Blood Pressure (OBP) monitoring
Number of subjects: 50
Study: 22246026

Group type: EXPERIMENTAL
Intervention: CGRP infusion (1.5 μg/min for 20 min)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Sumatriptan (6 mg subcutaneous)
Number of subjects: 18
Study: 19439741

Group type: EXPERIMENTAL
Intervention: Capecitabine
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard chemotherapy (cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide plus doxorubicin)
Number of subjects: 600
Study: 18026240

Group type: EXPERIMENTAL
Intervention: Zuidex (4 x 1.4 mL) submucosally injected
Number of subjects: 4
Study: 15532079

Group type: EXPERIMENTAL
Intervention: Dornase alpha (2.5 mg daily)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 48
Study: 11988603

Group type: EXPERIMENTAL
Intervention: Transcranial Doppler (TCD) examination
Number of subjects: 47
Study: 11133852

Group type: EXPERIMENTAL
Intervention: 0.05% cyclosporin A
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: 0.1% cyclosporin A
Number of subjects: 158

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 158
Study: 9772947

Group type: EXPERIMENTAL
Intervention: Daflon 500 mg (2 tablets)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 7840711

Group type: EXPERIMENTAL
Intervention: Erythromycin, Macropen, Azithromycin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 0
Study: 3046629

Group type: EXPERIMENTAL
Intervention: Capozide 25/15
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Capozide 50/15
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24